Zinzino Group revenue increased with a total of 60% in Q1 compared with the previous year.
The revenue in March for Zinzino’s sales markets increased by 79% and amounted to SEK 268.0 (USD $149.7) million.
Faun Pharma’s external sales decreased and amounted to SEK 7.1 (USD $9.8 ) million.
Overall, the Group increased revenues by 72% to SEK 275.1 (USD $159.5) million compared with the previous year.
The group revenue increased with 60% for Q1 2025 compared with the first quarter last year and amounted to SEK 725.9 (USD $454.5) million.
Revenues were distributed as follows:

Regions, mSEK

25-Mar

24-Mar

Change

Q1 2025

Q1 2024

Change

The Nordics

26.4

23.0

15 %

77.0

68.1

13 % increase

Central Europe

71.1

41.7

71 %

197.9

119.5

66 % increase

East Europe

34.0

31.9

7 %

97.3

93.8

4 % increase

South & West Europe

43.8

25.6

71 %

126.1

70.6

79 % increase

The Baltics

9.7

7.8

24 %

28.9

23.8

21 % increase

North America

56.1

13.5

316 %

112.2

35.4

217 % increase

Asia-Pacific

24.8

5.0

396 %

65.3

12.4

427 % increase

Africa

2.1

1.2

75 %

5.1

3.3

55 % increase

Zinzino

268.0

149.7

79 %

709.8

426.9

66 % increase

Faun Pharma

7.1

9.8

-28 %

16.1

27.6

42 % decrease

Zinzino Group

275.1

159.5

72 %

725.9

454.5

60 % increase

Countries in Each Region:
– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden– Central Europe: Austria, Germany, Switzerland– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands– The Baltics: Estonia, Latvia, Lithuania– North America: Canada, USA, Mexico– Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand– Africa: South Africa
To read the Zinzino Preliminary Sales Report Q1 2025, please visit Zinzino.com
About Zinzino
Zinzino is a global direct sales company from Scandinavia specializing in

Read more...